Cellular Processing Services at Biovault
Biovault specialises in the processing, storage, and distribution of cellular products and human tissues for clinical and research purposes.
With a fully accredited Good Manufacturing Practice (GMP) facility and expertise in advanced cellular therapies, we support organisations from initial research to full-scale production.
Partner with Biovault for advanced cellular processing, storage, and distribution.
Comprehensive Cellular Processing Services
Biovault processes minimally manipulated products for human application, subject to regulatory approval from the Human Tissue Authority (HTA). Our services align with the highest industry standards, including Good Distribution Practice (GDP) and those set out by our MHRA WDA(H) licence.
Our Cellular Products
We process, store, and distribute a range of cellular products, including:
Haematopoietic Progenitor Cells (HPCs):
HPC (A): Apheresis-derived stem cells.
HPC (M): Marrow-derived stem cells.
HPC (CB): Cord blood-derived stem cells.
T-Cell Products:
TC-T therapies and CAR-T cell therapies for immunotherapy.
Cellular Therapies
Biovault supports the development and delivery of cutting-edge cellular therapies, including:
Peripheral Blood Stem Cells (PBSCs): Processed and stored for transplantation and research.
Donor Lymphocyte Infusion (DLI): Supporting cellular therapy applications to enhance patient outcomes.
Immune Effector Cells (IECs): Processing, storage and release under our MHRA WDA(H) license terms.
Tissue Services
Biovault has decades of experience in the expert processing of a variety of human tissues for clinical and research applications. These include, but are not limited to:
Bone Products: Femoral heads, calcaneus, morselised bone and chipped bone for orthopaedic and reconstructive surgeries.
Soft Tissues: Tendons, ligaments, menisci, fascia lata, and skin grafts to support diverse medical applications, including sports injuries and reconstructive procedures.
Umbilical Cord Tissue: Stored and processed for regenerative medicine and advanced research purposes.
Supporting Research and Healthcare Organisations
Biovault partners with Contract Research Organisations (CROs), the NHS, and laboratories to deliver tailored cellular processing solutions:
CRO Outsourcing: Expertise in blood fractionation for research and clinical applications.
Advanced Assays: Offering Flow Cytometry and CFU (Colony Forming Unit) assays for cell characterisation and quality assessment.
Cell Culture and Expansion: Providing high-quality cell culture services for research and clinical scale-up.
Processing and Storage of HSCs: Expertise in the preparation and cryopreservation of haematopoietic stem cells (HSCs).
Why Choose Biovault for Cellular and Tissue Processing?
Accredited Facilities: Our GMP-compliant facility ensures regulatory adherence and product quality.
Expertise in Cellular and Tissue Therapies: Extensive experience in the preparation of stem cells, T-cell products, and human tissues.
Integrated Solutions: From processing and storage to distribution, we deliver end-to-end services.
Supporting Innovation: Collaborating with CROs and research institutions to advance cellular and tissue-based therapies.
Proven Track Record: Trusted by the NHS, laboratories, and global organisations for high-quality cellular and tissue processing services.